DaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research · 1 day ago
DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?Zacks Investment Research · 2 days ago
DaVita Inc. $DVA Position Lifted by CWA Asset Management Group LLCDefense World · 4 days ago
DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference CallPRNewsWire · 5 days ago
18,685 DaVita Inc. $DVA Shares Acquired by Counterpoint Mutual Funds LLCDefense World · Oct 18, 2026
DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney CarePRNewsWire · Oct 15, 2026DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD).
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | $3.88 | $4.02 | Beat |
| May 5, 2026 | $2.41 | $2.87 | Beat |
| Feb 2, 2026 | $3.24 | $3.40 | Beat |
| Oct 29, 2025 | $3.17 | $2.51 | Miss |
| Aug 5, 2025 | $2.70 | $2.95 | Beat |
| May 12, 2025 | $1.95 | $2.00 | Beat |